FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gary Rosner

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Living Beings

Activities & Behaviors

Computer Simulation

Co-author Network

Publications

TOP 3
Jennifer J Griggs; William M Hryniuk; Gary H Lyman; Pamela B Mangu; Vicki A Morrison; T May Pini; Gary Rosner; Carolyn D Runowicz; Michelle Shayne; Alex Sparreboom; Lara E Sucheston; Holly Anderson; Edward P Balaban; James J Dignam
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
Lorenzo Trippa; Gary Rosner; Peter Müller
Bayesian enrichment strategies for randomized discontinuation trials.
Dongfeng Wu; Karen Kafadar; Gary Rosner; Lyle D Broemeling
The lead time distribution when lifetime is subject to competing risks in cancer screening.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gary Rosner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jennifer J Griggs; William M Hryniuk; Gary H Lyman; Pamela B Mangu; Vicki A Morrison; T May Pini; Gary Rosner; Carolyn D Runowicz; Michelle Shayne; Alex Sparreboom; Lara E Sucheston; Holly Anderson; Edward P Balaban; James J Dignam
Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(13):1553-61.
2012: Lorenzo Trippa; Gary Rosner; Peter Müller
Bayesian enrichment strategies for randomized discontinuation trials.
Biometrics 2012;68(1):203-11.
2012: Dongfeng Wu; Karen Kafadar; Gary Rosner; Lyle D Broemeling
The lead time distribution when lifetime is subject to competing risks in cancer screening.
The international journal of biostatistics 2012;8(1):.
2012: Laura B Ramsey; Yiping Fan; Lisa R Treviño; Cheng Cheng; Paul Scheet; Wenjian Yang; Gitte H Bruun; Alex Sparreboom; Ching-Hon Pui; Selina Vattathil; Gary Rosner; Thomas J Corydon; William E Evans; Kathleen M Giacomini; Torben S Mikkelsen; Mary V Relling
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition.
Genome research 2012;22(1):1-8.
2011: Min-Yu Chen; Violeta Hennessey; Warren S-L Liao; Zhen Lu; Gary Rosner; Michele N Washington; Yinhua Yu; Ahmed Ashour Ahmed; William G Bornmann; Robert C Bast
Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.
Cancer 2011;117(19):4424-38.
2011: Dongfeng Wu; Diane Erwin; Gary Rosner
Sojourn time and lead time projection in lung cancer screening.
Lung cancer (Amsterdam, Netherlands) 2011;72(3):322-6.
2010: Violeta G Hennessey; Gary Rosner; Robert C Bast; Min-Yu Chen
A Bayesian approach to dose-response assessment and synergy and its application to in vitro dose-response studies.
Biometrics 2010;66(4):1275-83.
2010: Thomas O Erb; Britta S von Ungern-Sternberg; Kathrin Keller; Gary Rosner; Damian Craig; Franz J Frei
Fentanyl does not reduce the incidence of laryngospasm in children anesthetized with sevoflurane.
Anesthesiology 2010;113(1):41-7.
2009: Dongfeng Wu; Diane Erwin; Gary Rosner
A projection of benefits due to fecal occult blood test for colorectal cancer.
Cancer epidemiology 2009;33(3-4):212-5.
2009: Xiangjun Gu; Ralph F Frankowski; Gary Rosner; Mary Relling; Bo Peng; Christopher I Amos
A modified forward multiple regression in high-density genome-wide association studies for complex traits.
Genetic epidemiology 2009;33(6):518-25.
2009: Maria De Iorio; Wesley O Johnson; Peter Müller; Gary Rosner
Bayesian nonparametric nonproportional hazards survival modeling.
Biometrics 2009;65(3):762-71.
2009: Janelle Hoskins; Gary Rosner; Mark J Ratain; howard mcleod; Federico Innocenti
Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan.
Pharmacogenomics 2009;10(7):1139-46.
2009: Patrick A Thompson; Gary Rosner; Katherine K Matthay; Theodore B Moore; Lisa R Bomgaars; Kenneth J Ellis; Jamie Renbarger; Stacey L Berg
Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study.
Cancer chemotherapy and pharmacology 2009;64(2):243-51.
2009: Federico Innocenti; Deanna L Kroetz; Erin G Schuetz; M Eileen Dolan; Jacqueline Ramírez; Mary Relling; Peixian Chen; Soma Das; Gary Rosner; Mark J Ratain
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(16):2604-14.
2009: Federico Innocenti; Snezana Mirkov; Ramamoorthy Nagasubramanian; Jacqueline Ramírez; Wanqing Liu; Wasim K Bleibel; Sunita J Shukla; Kathy Hennessy; Gary Rosner; Edwin H Cook; M Eileen Dolan; Mark J Ratain
The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds.
Cancer chemotherapy and pharmacology 2009;63(5):881-7.
2009: Hui Yang; Tapan Kadia; Lianchun Xiao; Carlos E Bueso-Ramos; Koyu Hoshino; Deborah Ann Thomas; Susan O'Brien; Elias Jabbour; Sherry Pierce; Gary Rosner; Hagop M Kantarjian; Guillermo Garcia-Manero
Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia.
Blood 2009;113(9):1892-8.
2009: Dongfeng Wu; Diane Erwin; Gary Rosner
Estimating key parameters in FOBT screening for colorectal cancer.
Cancer causes & control : CCC 2009;20(1):41-6.
2008: Patrick A Thompson; Manish Gupta; Gary Rosner; Alexander Yu; Jeffrey Barrett; Lisa R Bomgaars; Mark L Bernstein; Susan M Blaney; John Mondick
Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group.
Cancer chemotherapy and pharmacology 2008;62(6):1027-37.
2008: Gary Rosner; J C Panetta; F Innocenti; Mark J Ratain
Pharmacogenetic pathway analysis of irinotecan.
Clinical pharmacology and therapeutics 2008;84(3):393-402.
2008: Meichun Ding; Gary Rosner; Peter Müller
Bayesian optimal design for phase II screening trials.
Biometrics 2008;64(3):886-94.
2008: Stella M Davies; Michael J Borowitz; Gary Rosner; Kristin Ritz; Meenakshi Devidas; Naomi Winick; Paul L Martin; Paul Bowman; James Elliott; Cheryl Willman; Soma Das; Edwin H Cook; Mary Relling
Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood 2008;111(6):2984-90.
2008: Guillermo Garcia-Manero; Hui Yang; Carlos E Bueso-Ramos; Alessandra Ferrajoli; Jorge Cortes; William G Wierda; Stefan Faderl; Charles Koller; Gail Morris; Gary Rosner; Andrey Loboda; Valeria R Fantin; Sophia S Randolph; James S Hardwick; John F Reilly; Cong Chen; Justin L Ricker; J Paul Secrist; Victoria M Richon; Stanley R Frankel; Hagop M Kantarjian
Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes.
Blood 2008;111(3):1060-6.
2007: Dongfeng Wu; Gary Rosner; Lyle D Broemeling
Bayesian inference for the lead time in periodic cancer screening.
Biometrics 2007;63(3):873-80.
2007: David Rossell; Peter Müller; Gary Rosner
Screening designs for drug development.
Biostatistics (Oxford, England) 2007;8(3):595-608.
2007: Lionel D Lewis; Antonius A Miller; Gary Rosner; Jonathan E Dowell; Manuel Valdivieso; Mary Relling; Merrill J Egorin; Robert R Bies; Donna Hollis; Ellis G Levine; Gregory A Otterson; Frederick Millard; Mark J Ratain
A comparison of the pharmacokinetics and pharmacodynamics of docetaxel between African-American and Caucasian cancer patients: CALGB 9871.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3302-11.
2007: Shinji Kishi; Cheng Cheng; Deborah French; Deqing Pei; Soma Das; Edwin H Cook; Nobuko Hijiya; Carmelo Rizzari; Gary Rosner; Tony Frudakis; Ching-Hon Pui; William Evans; Mary Relling
Ancestry and pharmacogenetics of antileukemic drug toxicity.
Blood 2007;109(10):4151-7.
2007: Patrick A Thompson; Daryl J Murry; Gary Rosner; Simon Lunagomez; Susan M Blaney; Stacey L Berg; Bruce M Camitta; ZoAnn E Dreyer; Lisa R Bomgaars
Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia.
Cancer chemotherapy and pharmacology 2007;59(6):847-53.
2007: Pulak Ghosh; Gary Rosner
A semi-parametric Bayesian approach to average bioequivalence.
Statistics in medicine 2007;26(6):1224-36.
2007: Peter Müller; Fernando A Quintana; Gary Rosner
Semiparametric bayesian inference for multilevel repeated measurement data.
Biometrics 2007;63(1):280-9.
2007: Xin Han; Guillermo Garcia-Manero; Timothy J McDonnell; Guillermina Lozano; L Jeffrey Medeiros; Lianchun Xiao; Gary Rosner; Martin Nguyen; Michael Fernandez; Yasmine A Valentin-Vega; Juan A Barboza; Daniel M Jones; George Z Rassidakis; Hagop M Kantarjian; Carlos E Bueso-Ramos
HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(1):54-62.
2006: Guillermo Garcia-Manero; Hagop M Kantarjian; Blanca Sanchez-Gonzalez; Hui Yang; Gary Rosner; Srdan Verstovsek; Michael Rytting; William G Wierda; Farhad Ravandi; Charles Koller; Lianchun Xiao; Stefan Faderl; Zeev Estrov; Jorge Cortes; Susan O'Brien; Elihu Estey; Carlos E Bueso-Ramos; Jackie Fiorentino; Elias Jabbour; Jean-Pierre J Issa
Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia.
Blood 2006;108(10):3271-9.
2006: Mark J Ratain; Tim Eisen; Walter M Stadler; Keith T Flaherty; Stan B Kaye; Gary Rosner; Martin Gore; Apurva A Desai; Amita Patnaik; Henry Q Xiong; Eric K Rowinsky; James L Abbruzzese; Chenghua Xia; Ronit Simantov; Brian Schwartz; Peter J O'Dwyer
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2505-12.
2006: Stuart M Lichtman; Donna Hollis; Antonius A Miller; Gary Rosner; Chris A Rhoades; Eric P Lester; Frederick Millard; John Byrd; Stephen A Cullinan; D Marc Rosen; Robert A Parise; Mark J Ratain; Merrill J Egorin
Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1846-51.
2006: Cheri E Klein; Helen Kastrissios; Antonius A Miller; Donna Hollis; Daohai Yu; Gary Rosner; David L Grinblatt; Richard A Larson; Mark J Ratain
Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study.
Cancer chemotherapy and pharmacology 2006;57(2):199-206.
2005: Dongfeng Wu; Gary Rosner; Lyle D Broemeling
MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening.
Biometrics 2005;61(4):1056-63.
2005: Lanlan Shen; Yutaka Kondo; Gary Rosner; Lianchun Xiao; Natalie Supunpong Hernandez; Jill Vilaythong; Patrick S Houlihan; Robert S Krouse; AR Prasad; Janine G Einspahr; Julie Buckmeier; David S Alberts; Stanley R Hamilton; Jean-Pierre J Issa
MGMT promoter methylation and field defect in sporadic colorectal cancer.
Journal of the National Cancer Institute 2005;97(18):1330-8.
2005: Donald E Thrall; Susan M LaRue; Daohai Yu; Thaddeus V Samulski; Linda Sanders; Beth Case; Gary Rosner; Chieko Azuma; Jean M Poulson; Amy F Pruitt; Wilma Stanley; Marlene L Hauck; Laurel Williams; Paul Hess; Mark Dewhirst
Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5206-14.
2005: Carlos E Bueso-Ramos; Yunling Xu; Timothy J McDonnell; Shawn Brisbay; Sherry Pierce; Andrew Lamb; Gary Rosner; Guillermo Garcia-Manero
Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(17):3932-9.
2005: Walter M Stadler; Gary Rosner; Eric Small; Donna Hollis; Brian I Rini; S Donald Zaentz; John Mahoney; Mark J Ratain
Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3726-32.
2005: William P Peters; Gary Rosner; James J Vredenburgh; Elizabeth J Shpall; Michael Crump; Paul G Richardson; Michael W Schuster; Lawrence Marks; Constance Cirrincione; Larry Norton; I Craig Henderson; Richard L Schilsky; David D Hurd
Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2191-200.
2005: Gary Rosner
Bayesian monitoring of clinical trials with failure-time endpoints.
Biometrics 2005;61(1):239-45.
2004: Antonius A Miller; Gary Rosner; Merrill J Egorin; Donna Hollis; Stuart M Lichtman; Mark J Ratain
Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8325-31.
2004: Mary Relling; Wenjian Yang; Soma Das; Edwin H Cook; Gary Rosner; Michael Neel; Scott Howard; Raul Ribeiro; John T Sandlund; Ching-Hon Pui; Sue C Kaste
Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(19):3930-6.
2004: Michael H Wu; Peixian Chen; Xiaolin Wu; Wanqing Liu; Stephen Strom; Soma Das; Edwin H Cook; Gary Rosner; M Eileen Dolan
Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 gene.
Pharmacogenetics 2004;14(9):595-605.
2004: E G Schuetz; Mary Relling; S Kishi; W Yang; S Das; P Chen; Edwin H Cook; Gary Rosner; Ching-Hon Pui; J G Blanco; M J Edick; M L Hancock; N J Winick; T Dervieux; M D Amylon; R O Bash; Frederick G. Behm; B M Camitta; S C Raimondi; B C Goh; S C Lee; L Z Wang; L Fan; J Y Guo; J Lamba; R Lim; H L Lim; A B Ong; H S Lee; P Kuehl; J Zhang; Y Lin; M Assem; J Schuetz; Paul B Watkins; A Daly; S A Wrighton; S D Hall; P Maurel; C Brimer; K Yasuda; R Venkataramanan; S Strom; K Thummel; M S Boguski
PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5.
Pharmacological reviews 2004;56(2):159.
2004: Shinji Kishi; Wenjian Yang; Benoit Boureau; Stanislas Morand; Soma Das; Peixian Chen; Edwin H Cook; Gary Rosner; Erin G Schuetz; Ching-Hon Pui; Mary Relling
Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia.
Blood 2004;103(1):67-72.
2003: A P Venook; C Enders Klein; G Fleming; D Hollis; C G Leichman; R Hohl; John Byrd; D Budman; M Villalona; J Marshall; Gary Rosner; J Ramirez; Helen Kastrissios; Mark J Ratain
A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(12):1783-90.
2003: Hedibert Freitas Lopes; Peter Müller; Gary Rosner
Bayesian meta-analysis for longitudinal data models using multivariate mixture priors.
Biometrics 2003;59(1):66-75.
2003: David A Rizzieri; Valerie K Ibom; Joseph O Moore; Carlos M DeCastro; Gary Rosner; David J Adams; Traci Foster; Nancy Payne; Maria Thompson; James J Vredenburgh; Cristina Gasparetto; Gwynn D Long; Nelson J Chao; Jon P Gockerman
Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):663-8.
2002: Gini F Fleming; Neal J Meropol; Gary Rosner; Donna Hollis; William E Carson; Michael Caligiuri; Joanne Mortimer; Katherine Tkaczuk; Robin Parihar; Richard L Schilsky; Mark J Ratain
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3718-27.
2002: Gary Rosner; Walter Stadler; Mark J Ratain
Randomized discontinuation design: application to cytostatic antineoplastic agents.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4478-84.
2002: Eric J Small; Susan Halabi; Mark J Ratain; Gary Rosner; Walter Stadler; David Palchak; Ernest Marshall; Randall Rago; Vera Hars; George Wilding; Daniel P Petrylak; Nicholas J Vogelzang
Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(16):3369-75.
2002: Adam J Bass; Jon P Gockerman; Eve Hammett; Carlos M DeCastro; David J Adams; Gary Rosner; Nancy Payne; Patti Davis; Traci Foster; Joseph O Moore; David A Rizzieri
Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(13):2995-3000.
2002: David A Rizzieri; Adam J Bass; Gary Rosner; Jon P Gockerman; Carlos M DeCastro; William P Petros; David J Adams; Mary J Laughlin; Patti Davis; Traci Foster; Robert Jacobson; Herbert I Hurwitz; Joseph O Moore
Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):674-9.
2001: Stacey A Snyder; Jennifer Lanzen; Rod D Braun; Gary Rosner; Timothy W Secomb; John E Biaglow; David M. Brizel; Mark Dewhirst
Simultaneous administration of glucose and hyperoxic gas achieves greater improvement in tumor oxygenation than hyperoxic gas alone.
International journal of radiation oncology, biology, physics 2001;51(2):494-506.
2001: PD Maguire; Thaddeus V Samulski; Leonard R Prosnitz; Ellen Jones; Gary Rosner; Barbara E Powers; L W Layfield; David M. Brizel; Sean P Scully; John M Harrelson; Mark Dewhirst
A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2001;17(4):283-90.
2001: Rod D Braun; Jennifer Lanzen; J A Turnage; Gary Rosner; Mark Dewhirst
Effects of the interaction between carbogen and nicotinamide on R3230 Ac tumor blood flow in Fischer 344 rats.
Radiation research 2001;155(5):724-33.
2001: Varsha Gandhi; William Plunkett; S Weller; Min Du; Mary Ayres; Carlos O Rodriguez; P Ramakrishna; Gary Rosner; JP Hodge; Susan O'Brien; Michael J Keating
Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2142-52.
2000: Donald E Thrall; Gary Rosner; Chieko Azuma; Susan M LaRue; Beth Case; Thaddeus V Samulski; Mark Dewhirst
Using units of CEM 43 degrees C T90, local hyperthermia thermal dose can be delivered as prescribed.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2000;16(5):415-28.
2000: M L Matteucci; G Anyarambhatla; Gary Rosner; Chieko Azuma; P E Fisher; Mark Dewhirst; david needham; Donald E Thrall
Hyperthermia increases accumulation of technetium-99m-labeled liposomes in feline sarcomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3748-55.
2000: RE Meyer; Rod D Braun; Gary Rosner; Mark Dewhirst
Local 42 degrees C hyperthermia improves vascular conductance of the R3230Ac rat mammary adenocarcinoma during sodium nitroprusside infusion.
Radiation research 2000;154(2):196-201.
2000: Alan P Venook; Merrill J Egorin; Gary Rosner; Donna Hollis; Sridhar Mani; M Hawkins; John Byrd; R Hohl; D Budman; N J Meropol; Mark J Ratain
Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(14):2780-7.
2000: Mitchell S. Anscher; Catherine Lee; Herbert I Hurwitz; Douglas Tyler; Leonard R Prosnitz; Paul S Jowell; Gary Rosner; Thaddeus V Samulski; Mark Dewhirst
A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer.
International journal of radiation oncology, biology, physics 2000;47(3):719-24.
1999: Leonard R Prosnitz; P Maguire; J M Anderson; Sean P Scully; John M Harrelson; Ellen Jones; Mark Dewhirst; Thaddeus V Samulski; Barbara E Powers; Gary Rosner; Richard K Dodge; Lester J Layfield; Robert Clough; David M. Brizel
The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy.
International journal of radiation oncology, biology, physics 1999;45(4):941-9.
1999: T J Dunn; Rod D Braun; W E Rhemus; Gary Rosner; Timothy W Secomb; Gillian M Tozer; David J Chaplin; Mark Dewhirst
The effects of hyperoxic and hypercarbic gases on tumour blood flow.
British journal of cancer 1999;80(1-2):117-26.
1998: Rogerio Lilenbaum; Antonius A Miller; G Batist; Stephen A Bernard; Donna Hollis; Gary Rosner; Merrill J Egorin; Richard L Schilsky; M J Ratain
Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3302-9.
1998: Alan P Venook; Merrill J Egorin; Gary Rosner; T D Brown; Thierry jahan; G Batist; R Hohl; D Budman; M J Ratain; C M Kearns; R L Schilsky
Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1811-9.
1998: J C Acker; Lawrence Marks; DP Spencer; W Yang; M A Avery; RK Dodge; Gary Rosner; Mark Dewhirst
Serial in vivo observations of cerebral vasculature after treatment with a large single fraction of radiation.
Radiation research 1998;149(4):350-9.
1997: Mark Dewhirst; Leonard R Prosnitz; Donald E Thrall; DM Prescott; S Clegg; C Charles; J MacFall; Gary Rosner; Thaddeus V Samulski; Edward L Gillette; Susan M LaRue
Hyperthermic treatment of malignant diseases: current status and a view toward the future.
Seminars in oncology 1997;24(6):616-25.
1997: B L Samuels; D R Hollis; Gary Rosner; D L Trump; Charles L Shapiro; N J Vogelzang; R L Schilsky
Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(11):1977-84.
1997: Donald E Thrall; Gary Rosner; C Azuma; M C McEntee; James Raleigh
Hypoxia marker labeling in tumor biopsies: quantification of labeling variation and criteria for biopsy sectioning.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;44(2):171-6.
1997: Antonius A Miller; Gary Rosner; M J Ratain; Donna Hollis; M R Green; Richard L Schilsky
Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(5):719-25.
1997: Gary Rosner; P Müller
Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models.
Journal of pharmacokinetics and biopharmaceutics 1997;25(2):209-33.
1997: J M Cline; Gary Rosner; James Raleigh; Donald E Thrall
Quantification of CCI-103F labeling heterogeneity in canine solid tumors.
International journal of radiation oncology, biology, physics 1997;37(3):655-62.
1997: J S Hahn; Rod D Braun; Mark Dewhirst; Siqing Shan; Stacey A Snyder; Janis M Taube; ET Ong; Gary Rosner; RK Dodge; Joseph Bonaventura; Celia Bonaventura; Joseph DeAngelo; RE Meyer
Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure.
Radiation research 1997;147(2):185-94.
1997: S Q Shan; Gary Rosner; Rod D Braun; J Hahn; C Pearce; Mark Dewhirst
Effects of diethylamine/nitric oxide on blood perfusion and oxygenation in the R3230Ac mammary carcinoma.
British journal of cancer 1997;76(4):429-37.
1996: Gary Rosner; J B Hargis; Donna Hollis; D R Budman; R B Weiss; I C Henderson; Richard L Schilsky
Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):3000-8.
1996: William P Petros; Gary Rosner; J Rabinowitz; C J Gilbert; David Coniglio; James J Vredenburgh; Maureen Ross; William P Peters
The pharmacologic effects of recombinant, human colony-stimulating factors and their modulation by theophylline.
Pharmacotherapy 1996;16(5):742-8.
1996: Mark Dewhirst; E T Ong; Gary Rosner; S W Rehmus; Siqing Shan; Rod D Braun; David M. Brizel; Timothy W Secomb
Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content.
The British journal of cancer. Supplement 1996;27():S241-6.
1996: Antonius A Miller; R C Lilenbaum; Thomas J Lynch; Gary Rosner; M J Ratain; M R Green; Richard L Schilsky
Treatment-related fatal sepsis from topotecan/cisplatin and topotecan/paclitaxel.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1964-5.
1996: Donald E Thrall; D M Prescott; Thaddeus V Samulski; Gary Rosner; D L Denman; R L Legorreta; R K Dodge; Rodney L Page; J M Cline; J Lee; B C Case; S M Evans; J R Oleson; Mark Dewhirst
Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas.
International journal of radiation oncology, biology, physics 1996;34(5):1087-96.
1996: Gary Rosner; S T Clegg; D M Prescott; Mark Dewhirst
Estimation of cell survival in tumours heated to nonuniform temperature distributions.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1996;12(2):303-4.
1996: Gary Rosner; ST Clegg; D M Prescott; Mark Dewhirst
Estimation of cell survival in tumours heated to nonuniform temperature distributions.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1996;12(2):223-39.
1995: James J Vredenburgh; William P Peters; Gary Rosner; Karen DeSombre; W W Johnston; A Kamel; K Wu; Robert C Bast
Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy: the role of induction chemotherapy.
Bone marrow transplantation 1995;16(6):815-21.
1995: C J Gilbert; K V Ohly; Gary Rosner; William P Peters
Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Cancer 1995;76(11):2330-7.
1995: R C Lilenbaum; M J Ratain; Antonius A Miller; J B Hargis; Donna Hollis; Gary Rosner; S M O'Brien; L Brewster; M R Green; Richard L Schilsky
Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(9):2230-7.
1995: David M. Brizel; Gary Rosner; Leonard R Prosnitz; Mark Dewhirst
Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases.
International journal of radiation oncology, biology, physics 1995;32(4):1121-5.
1995: L Cartee; William P Petros; Gary Rosner; Colleen Gilbert; S Moore; M L Affronti; J A Hoke; A M Hussein; Maureen Ross; P Rubin
Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study.
Cytokine 1995;7(5):471-7.
1995: Mark J Ratain; Gary Rosner; S L Allen; M Costanza; David A Van Echo; I C Henderson; Richard L Schilsky
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):741-7.
1995: Gary Rosner; D A Berry
A Bayesian group sequential design for a multiple arm randomized clinical trial.
Statistics in medicine 1995;14(4):381-94.
1995: Ronald A Fleming; R L Capizzi; Gary Rosner; L K Oliver; S J Smith; Charles Alan Schiffer; R T Silver; B A Peterson; R B Weiss; G A Omura
Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study.
Cancer chemotherapy and pharmacology 1995;36(5):425-30.
1994: Lawrence Marks; Gary Rosner; Leonard R Prosnitz; Maureen Ross; James J Vredenburgh; William P Peters
The impact of conventional plus high dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local-regional radiotherapy for breast cancer.
Cancer 1994;74(11):2964-71.
1994: Antonius A Miller; J B Hargis; R C Lilenbaum; S Z Fields; Gary Rosner; Richard L Schilsky
Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2743-50.
1994: Gary Rosner; P Müller
Pharmacodynamic analysis of hematologic profiles.
Journal of pharmacokinetics and biopharmaceutics 1994;22(6):499-524.
1994: David M. Brizel; Gary Rosner; John M Harrelson; Leonard R Prosnitz; Mark Dewhirst
Pretreatment oxygenation profiles of human soft tissue sarcomas.
International journal of radiation oncology, biology, physics 1994;30(3):635-42.
1994: S T Clegg; Thaddeus V Samulski; K A Murphy; Gary Rosner; Mark Dewhirst
Inverse techniques in hyperthermia: a sensitivity study.
IEEE transactions on bio-medical engineering 1994;41(4):373-82.
1994: J M Cline; D E Thrall; Gary Rosner; James Raleigh
Distribution of the hypoxia marker CCI-103F in canine tumors.
International journal of radiation oncology, biology, physics 1994;28(4):921-33.
1994: Thomas E Keane; J R Gingrich; Gary Rosner; K S Webb; S H Poulton; P J Walther
Combination versus single agent therapy in effecting complete therapeutic response in human bladder cancer: analysis of cisplatin and/or 5-fluorouracil in an in vivo survival model.
Cancer research 1994;54(2):475-81.
1994: Loretta DiPietro; A M Ostfeld; Gary Rosner
Adiposity and stroke among older adults of low socioeconomic status: the Chicago Stroke Study.
American journal of public health 1994;84(1):14-9.
1993: N Z Wu; Bruce Klitzman; Gary Rosner; david needham; Mark Dewhirst
Measurement of material extravasation in microvascular networks using fluorescence video-microscopy.
Microvascular research 1993;46(2):231-53.
1993: Stuart M Lichtman; M J Ratain; David A Van Echo; Gary Rosner; Merrill J Egorin; Daniel R Budman; N J Vogelzang; Larry Norton; R L Schilsky
Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study.
Journal of the National Cancer Institute 1993;85(16):1319-26.
1993: William P Peters; Gary Rosner; Maureen Ross; James J Vredenburgh; Barry Meisenberg; Colleen Gilbert; Joanne Kurtzberg
Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
Blood 1993;81(7):1709-19.
1993: David M. Brizel; Bruce Klitzman; J M Cook; J Edwards; Gary Rosner; Mark Dewhirst
A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model.
International journal of radiation oncology, biology, physics 1993;25(2):269-76.
1992: Mark Dewhirst; E T Ong; D Madwed; Bruce Klitzman; Timothy W Secomb; David M. Brizel; J Bonaventura; Gary Rosner; B Kavanagh; J Edwards
Effects of the calcium channel blocker flunarizine on the hemodynamics and oxygenation of tumor microvasculature.
Radiation research 1992;132(1):61-8.
1992: Mark Dewhirst; R Z Vinuya; E T Ong; Bruce Klitzman; Gary Rosner; Timothy W Secomb; J F Gross
Effects of bradykinin on the hemodynamics of tumor and granulating normal tissue microvasculature.
Radiation research 1992;130(3):345-54.
1992: SM Gillette; Mark Dewhirst; Edward L Gillette; D E Thrall; R L Page; Barbara E Powers; Stephen J Withrow; Gary Rosner; C Wong; D A Sim
Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: a randomized phase II study.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1992;8(3):309-20.
1992: John R Perfect; M E Klotman; C C Gilbert; D D Crawford; Gary Rosner; K A Wright; William P Peters
Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients.
The Journal of infectious diseases 1992;165(5):891-7.
1992: Rodney L Page; Dennis W Macy; Gregory K Ogilvie; Gary Rosner; Mark Dewhirst; Donald E Thrall; Stephen J Withrow; M C McEntee; J M Cline; G L Heidner
Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1992;8(2):187-97.
1992: Lawrence Marks; Edward C Halperin; Leonard R Prosnitz; Maureen Ross; James J Vredenburgh; Gary Rosner; W Peters
Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with greater than or equal to 10 positive axillary lymph nodes. Cancer and Leukemia Group B.
International journal of radiation oncology, biology, physics 1992;23(5):1021-6.
1992: J S Penta; Gary Rosner; D L Trump
Choice of starting dose and escalation for phase I studies of antitumor agents.
Cancer chemotherapy and pharmacology 1992;31(3):247-50.
1991: Gary Rosner
Use of DNA probes in paternity testing.
Clinical laboratory science : journal of the American Society for Medical Technology 1991;4(6):336-8.
1991: Thomas E Keane; Gary Rosner; J R Gingrich; S H Poulton; P J Walther
The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer.
The Journal of urology 1991;146(5):1418-24.
1991: E J Shpall; R B Jones; Robert C Bast; Gary Rosner; R Vandermark; Maureen Ross; M L Affronti; C Johnston; S Eggleston; M Tepperburg
4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(1):85-93.
1990: Mark Dewhirst; D M Prescott; ST Clegg; Thaddeus V Samulski; Rodney L Page; Donald E Thrall; K Leopold; Gary Rosner; J C Acker; J R Oleson
The use of hydralazine to manipulate tumour temperatures during hyperthermia.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1990;6(6):971-83.
1990: Thomas E Keane; Gary Rosner; J T Donaldson; D L Norwood; S H Poulton; P J Walther
Dipyridamole-cisplatin potentiation: enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers.
The Journal of urology 1990;144(4):1004-9.
1989: Gary Rosner; Anastasios A Tsiatis
The impact that group sequential tests would have made on ECOG clinical trials.
Statistics in medicine 1989;8(4):505-16.
1984: Anastasios A Tsiatis; Gary Rosner; C R Mehta
Exact confidence intervals following a group sequential test.
Biometrics 1984;40(3):797-803.